Zobrazeno 1 - 10
of 21
pro vyhledávání: '"T Higginson"'
Publikováno v:
Pharmacogenetics and Genomics. 29:155-157
Publikováno v:
American Journal of Health-System Pharmacy. 75:594-595
Tenofovir disoproxil fumarate tablets and the combination tablets that contain that agent plus emtricitabine may be administered enterally in crushed form and maintain suppression of viral load in patients with HIV infection.[1][1] It is generally re
Autor:
F Hussain, Damien Mullan, K Harris, P Chowdury, J. S. Dyer, K McBride, C Butterfield, S Punekar, S Glancy, S. Stephenson, S Docherty, D Fleming, A Edwards, A. Thrower, K Vallance, A Collins, J. Atchley, K Yap, Jonathan Richenberg, Julian Y Keanie, N.I. Dodds, Michaela Goodwin, P McLean, S Heyward, D.J. Tolan, R Bhat, Hans-Ulrich Laasch, E Moss, Giles Maskell, P Ellis, P Kennedy, Clive Kay, J Hancock, S Jackson, D. A. Brown, Andy Lowe, B Thomas, A.J. Lopez, T Higginson, R Briggs, P. Thompson, M. Robinson, M Johnston, S Krishnan, A Philips, C Corr, T Doyle
Publikováno v:
Clinical Radiology. 67:843-854
Aims To evaluate the variance in current UK clinical practice and clinical outcomes for direct percutaneous radiologically inserted gastrostomy (RIG). Materials and methods A prospective UK multicentre survey of RIG performed between October 2008 and
Autor:
Lonnie W. Aarssen, M. T. Higginson
Publikováno v:
The Open Anthropology Journal. 4:60-65
In most developed countries, gender equality and neutrality have been widely promoted and embraced— through public policy—as a socio-cultural goal since at least the mid-twentieth century. Accordingly, we predicted that a population of highly edu
Publikováno v:
Pharmacotherapy. 28:945-949
Highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) has resulted in significant morbidity and mortality reductions. Lifelong antiretroviral therapy must be incorporated into each patient's medical regimen. Patients wit
Publikováno v:
Annals of Pharmacotherapy. 38:1660-1663
OBJECTIVE To report a case of pancreatitis associated with the combined use of didanosine and tenofovir. Case Summary A 51-year-old white man with HIV was initiated on antiretroviral therapy with didanosine 250 mg/day, tenofovir 300 mg/day, lamivudin
Autor:
Evelyn J. Fisher, Robert T. Higginson, Nancy L. McCain, Debra E. Lyon, Jane Settle, Jo Lynne W. Robins
Publikováno v:
Journal of the Association of Nurses in AIDS Care. 9:19-23
HIV-related symptomatology represents both an indirect measure of immune functioning and a clinically significant indicator of disease progression. The most widely used classification system for HIV-related symptomatology is the Center for Disease Co
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 68(21)
Purpose The pharmacokinetic interaction of etravirine and raltegravir is reviewed, with discussion of implications for clinical practice. Summary Etravirine (a second-generation nonnucleoside reverse transcriptase inhibitor) and raltegravir (an integ
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.